Skip to main content
Premium Trial:

Request an Annual Quote

Ian Mehr, Gerald Wagner, Gary Carter, Richard Begley


ADMET company Qualyst has promoted Ian Mehr to vice president of business development. Mehr joined Qualyst in 2003 and has responsibility for major account licensing activity, management the firm's ongoing MDS alliance, and all marketing activities.

IntegraGen has appointed Gerald Wagner to the board of directors. Wagner, an independent consultant, had been president of Agfa Matrix Division at Agfa Corporation, and elected to the Agfa-Gevaert board. He received his PhD from the Technical University in Darmstadt, Germany.

CeMines has appointed Gary Carter as vice president of corporate development. Carter comes to CeMines from Transgenomic, where he was responsible for market research. He had also been manager of market research at Proligo, where he worked with product managers to determine optimal marketing and promotional strategies for new nucleic acid products.

Carter earned a master's degree in marketing research from the University of Georgia and a bachelor's degree in business administration from the University of South Carolina.

Ensemble Discovery has named Richard Begley as president and CEO. Begley had been serving as president and CEO of 454 Corporation. Before joining 454, Begley served in a variety of senior management positions at Agilent Technologies, Hewlett-Packard, Schlumberger Automated Test Equipment, PerkinElmer, and Los Alamos National Laboratory. He received his PhD and MS in applied physics from Stanford University.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.